Tagawa ST - Search Results

1

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.

van der Mijn JC, Eng KW, Chandra P, Fernandez E, Ramazanoglu S, Sigaras A, Oromendia C, Gudas LJ, Tagawa ST, Nanus DM, Faltas BF, Beltran H, Sternberg CN, Elemento O, Sboner A, Mosquera JM, Molina AM. van der Mijn JC, et al. Among authors: tagawa st. Mol Oncol. 2022 Jun;16(12):2384-2395. doi: 10.1002/1878-0261.13204. Epub 2022 Apr 5. Mol Oncol. 2022. PMID: 35231161 Free PMC article.

2

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

Gleghorn JP, Pratt ED, Denning D, Liu H, Bander NH, Tagawa ST, Nanus DM, Giannakakou PA, Kirby BJ. Gleghorn JP, et al. Among authors: tagawa st. Lab Chip. 2010 Jan 7;10(1):27-9. doi: 10.1039/b917959c. Epub 2009 Nov 16. Lab Chip. 2010. PMID: 20024046 Free PMC article.

3

Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer.

Tagawa ST, Beltran H, Vallabhajosula S, Goldsmith SJ, Osborne J, Matulich D, Petrillo K, Parmar S, Nanus DM, Bander NH. Tagawa ST, et al. Cancer. 2010 Feb 15;116(4 Suppl):1075-83. doi: 10.1002/cncr.24795. Cancer. 2010. PMID: 20127956 Free PMC article.

4

Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer.

Jeske S, Tagawa ST, Olowokure O, Selzer J, Giannakakou P, Nanus DM. Jeske S, et al. Among authors: tagawa st. Urol Oncol. 2011 Nov-Dec;29(6):676-81. doi: 10.1016/j.urolonc.2009.12.023. Epub 2010 May 7. Urol Oncol. 2011. PMID: 20451413

5

Primary squamous cell carcinoma of the urinary bladder presenting as peritoneal carcinomatosis.

Beltran H, Robinson BD, Tagawa ST. Beltran H, et al. Among authors: tagawa st. Adv Urol. 2010;2010:179250. doi: 10.1155/2010/179250. Epub 2010 Jun 27. Adv Urol. 2010. PMID: 20672052 Free PMC article.

6

A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981.

Tagawa ST, Milowsky MI, Jeske S, Mazumdar M, Kung S, Sung M, Lehrer D, Matulich D, Selzer J, Wright JJ, Nanus DM. Tagawa ST, et al. Am J Clin Oncol. 2011 Oct;34(5):443-8. doi: 10.1097/COC.0b013e3181e9c0d7. Am J Clin Oncol. 2011. PMID: 20881475 Clinical Trial.

7

Boning up on prognostic factors in advanced renal cell carcinoma.

Tagawa ST. Tagawa ST. Ann Oncol. 2011 Apr;22(4):751-753. doi: 10.1093/annonc/mdq705. Ann Oncol. 2011. PMID: 21447620 Free article. No abstract available.

8

New therapies for castration-resistant prostate cancer: efficacy and safety.

Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, Kelly WK, Saad F, Sternberg C, Tagawa ST, Tannock IF. Beltran H, et al. Among authors: tagawa st. Eur Urol. 2011 Aug;60(2):279-90. doi: 10.1016/j.eururo.2011.04.038. Epub 2011 May 4. Eur Urol. 2011. PMID: 21592649 Review.

9

Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer.

Darshan MS, Loftus MS, Thadani-Mulero M, Levy BP, Escuin D, Zhou XK, Gjyrezi A, Chanel-Vos C, Shen R, Tagawa ST, Bander NH, Nanus DM, Giannakakou P. Darshan MS, et al. Among authors: tagawa st. Cancer Res. 2011 Sep 15;71(18):6019-29. doi: 10.1158/0008-5472.CAN-11-1417. Epub 2011 Jul 28. Cancer Res. 2011. PMID: 21799031 Free PMC article.

10

Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.

Tagawa ST, Beltran H. Tagawa ST, et al. Asian J Androl. 2011 Nov;13(6):785-6. doi: 10.1038/aja.2011.113. Epub 2011 Aug 22. Asian J Androl. 2011. PMID: 21857690 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page